Browse Category

Stock Market News 13 December 2025 - 14 December 2025

BHP Group Ltd (BHP) Stock: This Week’s Key News, Price Drivers, and the Week-Ahead Outlook (Updated Dec. 14, 2025)

BHP Group Ltd (BHP) Stock: This Week’s Key News, Price Drivers, and the Week-Ahead Outlook (Updated Dec. 14, 2025)

BHP closed at A$45.59 on the ASX Friday, up 1.67% for the week, and $59.64 in New York. The company announced a US$2 billion infrastructure deal with Global Infrastructure Partners, retaining 51% control of a Western Australia iron ore power network. Copper prices neared $12,000/ton, boosting sentiment around BHP’s exposure to the metal.
Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NU) Stock Update: Brazil Banking-License Push, Colombia’s 4M Milestone, and Key Catalysts for the Week Ahead (Updated Dec. 12, 2025)

Nu Holdings (NYSE: NU) closed Dec. 12, 2025, at about $16.90, recovering after a 5.38% drop on Dec. 5 and ending the week up 1.2%. The company disclosed plans to seek a full banking license in Brazil by 2026, citing regulatory changes. Bloomberg reported Nu may consider acquiring a small Brazilian bank, with Banco Digimais named as a possible target. Nubank serves over 110 million customers in Brazil.
14 December 2025
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) surged 38% in five sessions, closing Dec. 12 at $37.96 on heavy volume, as speculation over a potential SpaceX IPO drew investor interest. The closed-end fund, which holds late-stage private tech firms, traded far above its net asset value. Friday’s volume hit 7.58 million shares, with pre-market activity also spiking. DXYZ’s price often moves on sentiment rather than underlying portfolio value.
14 December 2025
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals said late Friday the FDA approved CARDAMYST (etripamil) as the first self-administered nasal spray for PSVT. MIST shares closed down 18.3% at $2.41 after volatile trading and heavy volume, but rebounded modestly after hours. CARDAMYST is expected in pharmacies in Q1 2026. In a Phase 3 trial, 64% of patients converted to normal rhythm within 30 minutes, compared to 31% on placebo.
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)Meta description: MercadoLibre (MELI) ended the week near $2,016 after a volatile stretch that included a 5% midweek drop, a new humanoid-robot warehouse pilot, and a $750 million bond deal. Here’s what moved the stock this week and what investors are watching next week. MercadoLibre, Inc. (NASDAQ: MELI) closed Friday, Dec. 12, 2025 at $2,015.89, finishing a choppy week that featured a sharp selloff on Wednesday and a rebound attempt into the close. StockAnalysis The headline catalyst in the final days of the week wasn’t earnings—it was automation and capital markets. MercadoLibre announced a
14 December 2025
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy closed at $81.65 on Dec. 12, down 1.8% from the prior week. Shares fell sharply early in the week before rebounding, following news of new Google Cloud and Meta energy agreements. The company raised its 2025–2026 earnings guidance and analysts issued fresh price targets.
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

Updated: December 12, 2025 — DoorDash, Inc. (NASDAQ: DASH) ended Friday at $227.49, up 1.32% on the day, with a market value of roughly $99.6 billion. FinanceCharts+1 It was a volatile week for DoorDash stock: shares slid hard midweek as investors repriced the competitive outlook in online grocery and “instant” delivery, then stabilized as attention turned back to DoorDash’s scale, expansion strategy, and a fresh round of analyst updates. Investing.com+2Barron’s+2 Below is a comprehensive, publication-ready look at what moved DoorDash stock this week, the latest DoorDash news, and the key catalysts for the week ahead (Dec. 15–19). DoorDash stock price
13 December 2025
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike shares closed Friday at $67.47, down 0.40% on the day but up 6.2% from Monday’s close after a volatile week. The stock rebounded midweek as the Federal Reserve cut rates by 25 basis points. Nike also named Venkatesh Alagirisamy as its first chief operating officer, restructuring senior leadership ahead of its Q2 earnings report on Dec. 18.
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
13 December 2025
Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers closed Friday at $64.15, down 2.9% after a volatile session that saw shares swing between $66.00 and $62.58. The company began allowing some U.S. retail clients to fund brokerage accounts with stablecoins, enabling direct transfers from crypto wallets. The move comes as investors weigh shifting U.S. rate policy and the firm's global expansion efforts.
13 December 2025
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Healthcare shares closed at $484.77 on Friday, ending the week nearly unchanged after a sharp 4% drop Wednesday on heavy volume. The midweek decline followed reports of possible Medicare reimbursement cuts under discussion in Congress. HCA remains below its late-November record high of $515.85. Trading volatility this week drew renewed focus to policy risk for hospital operators.
13 December 2025
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin shares closed at $480.25 on Friday, Dec. 12, 2025, capping a nine-session winning streak despite a broader market decline. The stock rose 6.2% over the week. Switzerland announced it will cut its planned F-35 jet purchase to stay within budget, raising questions about future order volumes. Trading volume reached about 1.38 million shares.
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Updated: Friday, December 12, 2025Ticker: Starbucks Corporation (NASDAQ: SBUX) Starbucks stock ended the week on a steadier note after a choppy stretch that included a sharp early-week dip and a rebound into Friday’s close. Heading into next week, investors are weighing three near-term forces: labor headlines (as the workers’ strike expands), operational initiatives tied to CEO Brian Niccol’s “Back to Starbucks” turnaround, and macro data that can swing consumer-facing names. SBUX closed Friday, Dec. 12 at $85.35, up modestly from last Friday’s $85.12, after falling as low as $82.28 on Tuesday before recovering across the rest of the week. Starbucks
CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025Company: CME Group Inc. (NASDAQ: CME) CME Group stock ended the week on a steadier footing after a midweek dip, closing at $273.55 on Friday, Dec. 12 (up 0.42% on the day). Finviz That finish capped a modest weekly gain driven by a familiar theme for exchange operators: volatility, volumes, and policy-driven market plumbing changes. This week’s CME story wasn’t about a single earnings headline. Instead, investors digested a fresh surge in trading activity (including record crypto participation), regulatory momentum around U.S. Treasury market clearing, and a macro backdrop that continues to feed demand for hedging
13 December 2025
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals shares closed at $452.04 Friday, up 2.26% for the week after rebounding from early losses. The move followed new pediatric data for CASGEVY, showing children ages 5–11 with sickle cell disease remained crisis-free for at least 12 months. Vertex plans global regulatory submissions in 2026. One beta thalassemia patient died from pre-transplant chemotherapy complications.
Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Parker-Hannifin Corporation (NYSE: PH) wrapped up a volatile week still sitting near fresh highs after a rapid run-up earlier in the week. Shares closed Friday at $884.87, down 1.59% on the day, after setting a new 52-week high of $901.31 on Dec. 11. Trading volume on Dec. 12 came in below the stock’s 50-day average, suggesting a bout of profit-taking rather than a broad rush for the exits. MarketWatch The main “bigger picture” narrative behind Parker-Hannifin stock remains unchanged: strong operating momentum (especially in aerospace), a raised fiscal-year outlook, and a major portfolio
13 December 2025
Southern Copper (SCCO) Stock This Week: Record-High Copper, Analyst Targets, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Southern Copper (SCCO) Stock This Week: Record-High Copper, Analyst Targets, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Southern Copper Corporation closed Friday at $142.41, down 3.54% after shares swung between $141.84 and $149.75. The move tracked copper prices, which neared $12,000/ton this week before retreating. Analyst sentiment remains cautious, with most 12-month targets below the current share price. Southern Copper reported record quarterly results and low cash costs in Q3.
13 December 2025

Stock Market Today

Shell share price in focus after Kazakhstan investment pause and PwC audit switch

Shell share price in focus after Kazakhstan investment pause and PwC audit switch

8 February 2026
Shell will pause new investments in Kazakhstan amid ongoing legal disputes over $16.5 billion in contested costs at major oilfields, CEO Wael Sawan said. Shell shares closed at 2,774.5 pence on Friday. The company repurchased 1.64 million shares on Feb. 6 as part of its ongoing buyback. Shell named PwC as auditor from 2027, replacing EY, which is under investigation by UK regulators.
RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

8 February 2026
RELX shares fell 4.6% to 2,145p on Friday, near a 52-week low, despite the FTSE 100 closing higher. The company disclosed a new buyback of 465,361 shares on Feb. 6 and has repurchased over 8.8 million shares since Jan. 2. Investors await RELX’s full-year 2025 results on Feb. 12 amid concerns over AI’s impact on its core business.
Glencore shares steady after Rio walks away — what to watch before Monday’s trade

Glencore shares steady after Rio walks away — what to watch before Monday’s trade

8 February 2026
Glencore shares closed up 0.6% at 478.10 pence Friday after Rio Tinto ended merger talks, issuing a “no intention to bid” statement. Glencore’s board rejected the proposed deal terms, citing concerns over valuation and governance. Attention now turns to possible asset sales, including its $5 billion Kazzinc stake, ahead of Glencore’s annual results on Feb. 18.
Go toTop